Estudios Observacionales y Programas de Soporte a Pacientes: Comentarios al Real Decreto 957/2020

This article aims to describe and comment the regulatory framework applicable to observational studies with medicines for human use foreseen in Royal Decree 957/2020. Likewise, it provides the opinion of the authors with respect the ongoing debate regarding the impact of such Royal Decree on the regime applicable to patient support programs.